National cohort of nearly 200 000 samples from 5,700 patients 2,300 donors pre- & post- #allogeneic#HSCT to understand, predict and treat complications.
PROJECT FOCUS: AZIMUT
Deciphering the biological mechanisms involved in the regulation of the anti-tumor response after #allogeneic#HSCT by #azithromycin. @MichonneauDavid Nicolas Vallet - Saint-Louis Research Institute (IRSL) @APHP ▶️ https://t.co/NWf2lvFJba
Supported projects
In search of new polymorphisms through exome studies
Alice Aarnink and Adèle Dhuyser shed light on the "EXOME" project to better understand the mechanisms of alloreactivity responsible for complications after #allogeneic#HSCT
▶️ https://t.co/YZdXckB73t
Focus on projects supported by CRYOSTEM
Read the full interview with Professor Emmanuel Drouet @IBS_Grenoble - role of ZEBRA PROTEIN (Z EBV replication activator) in the development of #lymphoprolifératives diseases (PTLD)
➡ https://t.co/sbKEdb13qq
CRYOSTEM participe au 22e congrès annuel de la @SFGM_TC#SFGMTC2023. Présentation de 2 posters : Strategies de valorisation de la collection (P36) et Étude ancillaire du protocole clinique #FIBRAPLO (P40). Consulter tous les posters sélectionnés ▶️ https://t.co/4FJrkPs3nu
Rincé, vidé, à plat, lessivé, éreinté ... 😫c'est ce que l'on ressent après 1 #greffedemoelleosseuse. Pourquoi ? Que faire pour aller mieux et reprendre une vie 'normale' ? ➡️ RDV 17/11 10h-12h en ligne💻ou à #Lille au congrès de @SFGM_TC. ✍️Inscriptions : https://t.co/FbiNyNoBuN
Interesting editorial about our last paper published today in @cellhostmicrobe https://t.co/Ckmoqqfumk
and the beautiful paper of Nguyen et al. In @CellCellPress https://t.co/dWxiqtK7Lc
We are pleased to introduce you to Julie AZEMA who is currently in her second year of a Master's degree in health engineering and biobank management at the @ESTBB_Lyon . Julie is currently doing an internship at @cryostem_FR .
L’azithromycine après une allogreffe de cellules souches hématopoïétiques augmenterait la rechute des hémopathies malignes https://t.co/PwivcUOFv3 (full story here: https://t.co/Kbr97cicNe) @Inserm@APHP@univ_paris_cite
#LT#TechAndCare : dans la catégorie #SantéMentale, pitch de la fondation HTC Project pour le projet NEWSPRINGFORME, outil de prise en charge de la santé mentale en complément de la santé physique des patients, et ce tout au long du parcours de greffe
@cryostem_FR
Last days to register to @cryostem_FR scientific day 2021.
👉Call for abstracts
👉 More information about program and submission https://t.co/FtfbDnUfzI.
Event under the aegis of @SFGM_TC
🙏🙏 #therakos@GileadSciences @MNK
Interested in joining the @cryostem_FR scientific day 2021?
👉Call for abstracts, deadline Sep 30
👉 More information about program and submission https://t.co/FtfbDnUfzI
Event under the aegis of @SFGM_TC
🙏🙏 #therakos@GileadSciences @MNK
Myélome, lymphome, aplasie médullaire, myélodysplasie, anémie de Fanconi, ou encore la plus connue : la leucémie.
Autant de maladies graves du sang pour lesquelles la greffe de moelle osseuse peut aider les patients à guérir.
@ModulBio & @cryostem_FR are presenting a poster at @ISBER_ORG 2020 virtual symposium as part of the management of the CRYO-LEA cohort (to predict late side effects in patients treated for #leukemia during childhood). https://t.co/qGJUgoycti